A randomised control trial of SEEG electrode placement methods

Phase 3

Completed

• Conditions: Drug resistant focal epilepsy; Nervous System Diseases

• Registration Number: ISRCTN17209025
• Lead Sponsor: niversity College London

Brief Summary

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34429470/ results (added 26/08/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-11-15
• Study Completion: 2019-05-31
• Last Update Posted: 24 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

1. Age 18-80 years
2. Drug refractory focal epilepsy
3. Deemed to require SEEG placement as part of routine clinical care following multidisciplinary team meeting decision
4. Informed consent from patient to undergo intracranial SEEG investigation as part of routine clinical care

Exclusion Criteria

1. Pregnancy
2. Uncorrectable coagulopathy
3. Lacking capacity to consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Surgical implantation time will be measured in minutes and seconds during surgery.